SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?


To: Mark Bartlett who wrote (1553)3/28/1999 4:28:00 PM
From: n.p.  Read Replies (2) | Respond to of 14101
 
It is going to get crazy peter was also telling me that
the fda will visit the dmx site and also
meet with the hpb. He did not say when but I hope very soon.
did you about that new aids drug that got approved last week
by glaxo called ziagen.
two things that bother me 1) new study 2) j/v deal
both of these are in dmx control I do not know why they are taking so long to finish. In rebecca's message she said they will
have at least ONE deal by may 31. how long for the other one?
The new study should have been out a while ago but they are moving
to slow , for somthing they have control over?
just my thoughts
n.p.



To: Mark Bartlett who wrote (1553)3/29/1999 10:26:00 PM
From: mappingworld  Read Replies (2) | Respond to of 14101
 
Hello Mark, came across this sexy quote:

Today we are seeing "a historic opportunity to buy smaller and mid-size" biotechs - an opportunity that presents a "fantastically attractive" risk/reward ratio according to Jim McCamant, Editor of the Medical Technology Stock Letter.

techstocks.com